| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20066834 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS20068128 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS20066130 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS20020649 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS20020650 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS44008948 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS44024155 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS44035634 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS44051718 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
| TVIS44051719 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MAPK1 |
|---|---|
| DrugBank ID | DB06641 |
| Drug Name | Perifosine |
| Target ID | BE0000923 |
| UniProt ID | P28482 |
| Regulation Type | |
| PubMed IDs | 16528479 |
| Citations | Knowling M, Blackstein M, Tozer R, Bramwell V, Dancey J, Dore N, Matthews S, Eisenhauer E: A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs. 2006 Sep;24(5):435-9. |
| Groups | Investigational |
| Direct Classification | Dialkyl phosphates |
| SMILES | CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL372764 |
